World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
78
Citations
25039
World Ranking
1070
National Ranking
557

Michael E. Berens publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Michael E. Berens sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 348 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Michael E. Berens D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael E. Berens sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 78 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Michael E. Berens is affiliated with the Translational Genomics Research Institute in the United States. Their research spans several fields, with a focus on biochemistry, genetics, molecular biology, and medicine. Within these broad areas, their work delves into subfields such as molecular biology, genetics, cancer research, oncology, and pulmonary and respiratory medicine.

The scientist's research topics include:

  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Extracellular Vesicles in Disease
  • Ferroptosis and Cancer Prognosis
  • CAR-T Cell Therapy Research
  • MicroRNA in Disease Regulation

Michael E. Berens has contributed frequently to several publication venues, notably:

  • Neuro-Oncology (36 publications)
  • Cancer Research (23 publications)
  • Neuro-Oncology Advances (7 publications)
  • Clinical Cancer Research (2 publications)
  • Journal of Neuro-Oncology (2 publications)

The scientist has collaborated extensively with several peers, including Nanyun Tang (32 joint publications), Yue Hao (16 joint publications), Jill S. Barnholtz-Sloan (15 joint publications), Sen Peng (15 joint publications), and Harshil Dhruv (14 joint publications).

Notable papers authored by Michael E. Berens include:

  • Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety, 2022, Cancer Discovery
  • Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis, 2020, Cancer Epidemiology Biomarkers & Prevention
  • Importance of the Intersection of Age and Sex to Understand Variation in Incidence and Survival for Primary Malignant Gliomas, 2021, Neuro-Oncology
  • Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma, 2020, Cancer Research
  • Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003, 2022, Clinical Cancer Research

Best Publications

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Vasanthi S. Viswanathan;Matthew J. Ryan;Harshil D. Dhruv;Shubhroz Gill

  • Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

    A. Giese;R. Bjerkvig;M.E. Berens;M. Westphal

  • Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

    Matthew J. Hangauer;Vasanthi S. Viswanathan;Matthew J. Ryan;Dhruv Bole

  • An anatomic transcriptional atlas of human glioblastoma

    Ralph B. Puchalski;Nameeta Shah;Jeremy Miller;Rachel Dalley

  • Molecular mechanisms of glioma cell migration and invasion.

    Tim Demuth;Michael E. Berens

  • Molecular targets of glioma invasion

    M. Nakada;M. Nakada;S. Nakada;T. Demuth;N. L. Tran

  • Dichotomy of astrocytoma migration and proliferation

    Alf Giese;Melinda A. Loo;Nhan Tran;Dorothy Haskett

  • Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.

    Dominique B. Hoelzinger;Tim Demuth;Michael E. Berens

  • Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis

    Bodour Salhia;Jeff Kiefer;Julianna T. D. Ross;Raghu Metapally

  • Cell migration and invasion assays.

    Aline Valster;Nhan L. Tran;Mitsutoshi Nakada;Michael E. Berens

  • Gene Expression Profile of Glioblastoma Multiforme Invasive Phenotype Points to New Therapeutic Targets

    Dominique B Hoelzinger;Luigi Mariani;Joachim Weis;Tanja Woyke

  • A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment.

    Andrew M. Stein;Tim Demuth;David Mobley;Michael Berens

  • SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

    Stephanie M. Robert;Susan C. Buckingham;Susan L. Campbell;Stefanie Robel

  • The Tumor Necrosis Factor-like Weak Inducer of Apoptosis (TWEAK)-Fibroblast Growth Factor-inducible 14 (Fn14) Signaling System Regulates Glioma Cell Survival via NFκB Pathway Activation and BCL-XL/BCL-W Expression

    Nhan L. Tran;Wendy S. McDonough;Benjamin A. Savitch;Thomas F. Sawyer

  • Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model.

    T. S. Deisboeck;M. E. Berens;A. R. Kansal;S. Torquato

  • Migration of human glioma cells on myelin.

    Alt Giese;Lan Kluwe;Britta Laube;Hildegard Meissner

  • Determinants of Human Astrocytoma Migration

    Alf Giese;Monique D. Rief;Melinda A. Loo;Michael E. Berens

  • An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.

    Michelle B. Mintz;Rebecca Sowers;Kevin M. Brown;Sara C. Hilmer

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

Frequent Co-Authors

Jill S. Barnholtz-Sloan
Jill S. Barnholtz-Sloan Case Western Reserve University
Justin D. Lathia
Justin D. Lathia Cleveland Clinic Lerner College of Medicine
James R. Connor
James R. Connor Pennsylvania State University
John D. Carpten
John D. Carpten University of Southern California
Michael D. Prados
Michael D. Prados University of California, San Francisco
Frank B. Furnari
Frank B. Furnari University of California, San Diego
Mark L. Rosenblum
Mark L. Rosenblum Henry Ford Health System
Marc Symons
Marc Symons Feinstein Institute for Medical Research
Jeffrey A. Winkles
Jeffrey A. Winkles University of Maryland, Baltimore
David Craig
David Craig University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their career options within healthcare and life sciences, there are several flexible online degree pathways to consider. Many choose to build on a foundation in molecular biology by transitioning into advanced nursing roles or other specialized healthcare careers.

Registered nurses looking to move into nurse practitioner roles can enroll in rn to np programs online to bridge the educational gap efficiently. Meanwhile, those from non-nursing backgrounds can enter the nursing field through an online direct entry msn program, opening new possibilities for career change.

Determining where to study is also important. Students comparing value and flexibility often evaluate best value nursing education online wgu when choosing the right fit for their schedule and budget. Additionally, for those who already hold a bachelor’s degree in nursing, enrolling in online bsn programs can be a cost-effective way to advance their credentials and skills.

These pathways support diverse goals—whether you are aiming for hands-on patient care, leadership, or research—while benefiting from the convenience and accessibility of accredited online learning.

Best Scientists Citing Michael E. Berens

Trending Scientists

Recently Published Articles